Hims & Hers GLP-1 Super Bowl Ad Sparks Debate On FDA Compliance

Telehealth company Hims & Hers Health is set to air its first Super Bowl ad Sunday (Feb. 9), promoting compounded weight-loss drugs -- sparking allegations from a bipartisan Senate duo, the Pharmaceutical Research and Manufacturers of America (PhRMA) and a public health group that the ad is misleading and goes against the intent of FDA’s prescription drug advertising rules. But the lobbying group for compounders, the Alliance for Pharmacy Compounding, argues the ad complies with FDA rules and asserts that...